Evidence map›Paper›PMID 41109888›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Improved olfactory function following high-frequency transcutaneous auricular vagal nerve stimulation in post-COVID-19 patients with olfactory dysfunction.

Susanne Weise, Mária Oravcová, Pauline Hanslik, Coralie Mignot, Yusuf Ozgur Cakmak, Thomas Hummel

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Comment on "Improved olfactory function following high-frequency transcutaneous auricular vagal nerve stimulation in post-COVID-19 patients with olfactory dysfunction".European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Susanne WeiseSmell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany. Susanne.weise@uniklinikum-dresden.de.ORCID http://orcid.org/0000-0001-7650-1731
Mária OravcováSmell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany.
Pauline HanslikSmell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany.
Coralie MignotSmell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany.
Yusuf Ozgur CakmakPoint-of-Care Technologies Theme, Centre for Bioengineering and Nanotechnology, Dunedin, New Zealand.
Thomas HummelSmell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrevious studies in healthy individuals showed that high-frequency but not the low frequency non-invasive vagal nerve stimulation improves olfactory function in healthy individuals. The present study aimed to analyze the potential effects of non-invasive, high-frequency transcutaneous auricular vagal nerve stimulation (TA-VNS) on olfactory function in patients with olfactory dysfunction (OD) and healthy individuals.

methodsPatients with post-COVID-19 associated OD (n = 10) and normosmic individuals (n = 30) performed olfactory testing (Sniffin` Sticks), trigeminal testing (lateralization test), attentional tests (d2 test), ratings of odor intensity and pleasantness before and after receiving a TA-VNS for 10 min. Patients with OD received only TA-VNS while normosmic subjects underwent, in addition to TA-VNS, placebo stimulation (control condition) with electrode placement of TA-VNS, and active-control transcutaneous stimulation at the forearm in a randomized order with a minimum 24-h interval between sessions.

resultsIn patients with OD intensity ratings for fish and pleasantness ratings for eucalyptol increased and olfactory discrimination improved (p = 0.017) as opposed to olfactory threshold (p = 0.18). For both, patients with OD and healthy individuals results of the d2 attention test improved following the TA-VNS. In healthy individuals, there were no differences in olfactory discrimination nor threshold regarding the 3 stimulation modalities (TA-VNS, placebo (control condition), transcutaneous stimulation).

conclusionThese results seem to underline the functional connection of the olfactory system with the afferent vagus network. However, a ceiling effect for olfactory discrimination did not allow to observe a possible improvement in normosmic individuals. Further studies in patients with OD are needed to characterize this potential therapeutic effect of TA-VNS.

Indexed as

COVID-19Olfaction DisordersTranscutaneous Electric Nerve StimulationVagus Nerve StimulationAdultFemaleHumansMaleMiddle AgedSARS-CoV-2SmellTreatment OutcomeCOVID-19OlfactionOlfactory dysfunctionSmellVagal nerve stimulation

Identifiers

PMID41109888
PMCPMC12680794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.